SEARCH

SEARCH BY CITATION

REFERENCES

  • Abdolmaleky HM, Smith CL, Faraone SV, Shafa R, Stone W, et al. 2004. Methylomics in psychiatry: Modulation of gene-environment interactions may be through DNA methylation. Am J Med Genet Part B Neuropsychiatr Genet 127B:5159.
  • Addington J. 2007. The promise of early intervention. J Early Interv 1:294307.
  • Addington J, Heinssen R. 2012. Prediction and prevention of psychosis in youth at clinical high risk. Annu Rev Clin Psychol 8:269289.
  • Addington J, Penn D, Wood SJ, Addington D, Perkins DO. 2008. Social functioning in individuals at clinical high risk for psychosis. Schizophr Res 99:119124.
  • Addington J, Cornblatt B, Cadenhead KS, Cannon TD, McGlashan TH, et al. 2011. At clinical high risk for psychosis: Outcome for nonconverters. Am J Psychiatry 168:800805.
  • Allan CL, Cardno AG, McGuffin P. 2008. Schizophrenia: From genes to phenes to disease. Curr Psychiatry Rep 10:339343.
  • Allen AJ, Griss ME, Folley BS, Hawkins KA, Pearlson GD. 2009. Endophenotypes in schizophrenia: A selective review. Schizophr Res 109:2437.
  • American Psychiatric Association. 1994. Diagnostic and statistical manual of mental disorders (DSM-IV). Washington, DC: American Psychiatric Association.
  • Andreasen NC. 1983. The scale for the assessment of negative symptoms (SANS). Iowa City, IA: The University of Iowa.
  • Ballon JS, Kaur T, Marks II, Cadenhead KS. 2007. Social functioning in young young people at risk for schizophrenia. Psychiatry Res 151:2935.
  • Bertelsen M, Jeppesen P, Petersen L, Thorup A, Øhlenschlæger J, et al. 2008. Five-year followup of a randomized multicenter trial of early intervention vs standard treatment for patients with a first episode of psychotic illness: The OPUS trial. Arch Gen Psychiatry 65:762771.
  • Bertelsen M, Jeppesen P, Petersen L, Thorup A, Øhlenschlæger J, et al. 2009. Course of illnessin s sample of 265 patients with first-episode psychosis—Five year follow-up of the Danish OPUS trial. Schizophr Res 107:173178.
  • Bhui K. 2008. Migration and mental health. In: Freeman H, Stansfeld S, editors. The impact of the environment on psychiatric disorder. London: Routledge. pp. 184209.
  • Bleuler E. 1911/1950. Dementia praecox or the group of schizophrenias. New York: International Universities Press.
  • Braff DL, Freedman R. 2002. The importance of endophenotypes in studies of the genetics of schizophrenia. In: Davis KL, Charney D, Coyle JT, Nemeroff C, editors. Neuropsychopharmacology: The fifth generation of progress. Philadelphia: Lippincott Williams & Wilkins. pp. 703716.
  • Braff DL, Freedman R, Schork NJ, Gottesman II. 2007. Deconstructing schizophrenia: An overview of the use of endophenotypes in order to understand a complex disorder. Schizophr Bull 33:2132.
  • Cannon M, Jones PB, Murray R. 2002. Obstetric complications and schizophrenia: Historical and meta-analytic review. Am J Psychiatry 159:10801092.
  • Cannon TD, Cadenhead KS, Cornblatt B, Wood SJ, Addington J, et al. 2008. Prediction of psychosis in youth at high clinical risk: A multisite longitudinal study in North America. Arch Gen Psychiatry 65:2837.
  • Chan RC, Gottesman II. 2008. Neurological soft signs as candidate endophenotypes for schizophrenia: A shooting star or a Northern star? Neurosci Biobehav Rev 32:951957.
  • Cornblatt B, Auther A, Niendam T, Smith CW, Zinberg J, et al. 2007. Preliminary findings for two new measures of social and role functioning in the prodromal phase of schizophrenia. Schizophr Bull 33:688702.
  • Craddock N, O'Donovan MC, Owen MJ. 2009. Psychosis genetics: Modeling the relationship between schizophrenia, bipolar disorder and mixed (or “schizoaffective”) psychoses. Schizophr Bull 35:482490.
  • Dazzan P, Kravariti E, Fearon P, Murray RM. 2004. Is the development of schizophrenia predictable? In: Stone WS, Faraone SV, Tsuang MT, editors. Early clinical intervention and prevention in schizophrenia. Totowa, NJ: Humana Press. pp. 225252.
  • Derogatis LR. 1993. Symptom checklist-90-R (SCL-90-R). Minneapolis, MN: Computer Systems, Inc.
  • Eack SM, Mermon DE, Montrose DM, Miewald J, Gur RE, et al. 2010. Social cognition deficits among individuals at familial high risk for schizophrenia. Schizophr Bull 36:10811088.
  • Erlenmeyer-Kimling L. 2001. Early neurobehavioral deficits as phenotypic indicators of the schizophrenia genotype and predictors of later psychosis. Am J Med Genet Neuropsychiatr Genet 105:2324.
  • Faraone SV, Kremen WS, Lyons MJ, Pepple JR, Seidman LJ, Tsuang MT. 1995a. Diagnostic accuracy and linkage analysis: How useful are schizophrenia spectrum phenotypes? Am J Psychiatry 152:12861290.
  • Faraone SV, Seidman LJ, Kremen WS, Pepple JR, Lyons MJ, Tsuang MT. 1995b. Neuropsychological functioning among the nonpsychotic relatives of schizophrenic patients: A diagnostic efficiency analysis. J Abnorm Psychol 104:286304.
  • Faraone SV, Green AI, Seidman LJ, Tsuang MT. 2001. “ Schizotaxia”: Clinical implications and new directions for research. Schizophr Bull 27:118.
  • Faraone SV, Seidman LJ, Kremen WS, Kennedy D, Makris N, et al. 2003. Structural brain abnormalities among relatives of patients with schizophrenia: Implications for linkage studies. Schizophr Res 60:125140.
  • Flint J, Munafo MR. 2007. The endophenotype concept in psychiatric genetics. Psychol Med 37:163180.
  • Fusar-Poli P, Meneghelli A, Valmaggia L, Allen P, Galvan F, et al. 2009. Duration of untreated prodromal symptoms and 12-month functional outcome of individuals at risk of psychosis. Br J Psychiatry 194:181182.
  • Fusar-Poli P, Borgwardt S, Bechdolf A, Addington J, Riech-Rossler A, et al. 2012a. The psychosis high risk state: A comprehensive state-of-the-art review. JAMA Psychiatry 70:107120.
  • Fusar-Poli P, Deste G, Smieskova R, Barlati S, Yung AR, et al. 2012b. Cognitive functioning in prodromal psychosis: A meta analysis. Arch Gen Psychiatry 69:562571.
  • Geddes JR, Lawrie SM. 1995. Obstetric complications and schizophrenia: A meta-analysis. Br J Psychiatry 167:786793.
  • Giuliano AJ, Li H, Mesholam-Gately R, Sorenson SM, Woodberry KA, Seidman LJ. 2012. Neurocognition in psychosis risk syndrome: A quantitative and qualitative review. Curr Pharmaceut Design 18:399415.
  • Glatt SJ, Faraone SV, Tsuang MT. 2007. Genetic risk factors for mental disorders: General principles and state of the science. In: Tsuang MT, Stone WS, Lyons MJ, editors. Recognition and prevention of major mental and substance use disorders. Washington, DC: American Psychiatric Publishing, Inc. pp. 320.
  • Gottesman II. 1991. Schizophrenia genesis: The origin of madness. New York: Freeman.
  • Gottesman II, Gould TD. 2003. The endophenotype concept in psychiatry: Etymology and strategic intentions. Am J Psychiatry 160:636645.
  • Gottesman II, Hanson DR. 2005. Human development: Biological and genetic processes. Annu Rev Psychol 56:263286.
  • Gottesman II, Shields J. 1972. Schizophrenia and genetics: A twin study vantage point. New York: Academic Press.
  • Gottesman II, Shields J. 1982. Schizophrenia: The epigenetic puzzle. Cambridge: Cambridge University Press.
  • Greenwood TA, Braff DL, Cadenhead KS, Calkins ME, Dobie DJ, et al. 2007. The consortium on the genetics of schizophrenia (COGS): Preliminary heritability analyses of endophenotypic measures for schizophrenia. Arch Gen Psychiatry 64:12421250.
  • Gur RE, Calkins ME, Gur RC, Horan WP, Neuchterlein KH, et al. 2007. The consortium on the genetics of schizophrenia (COGS): Neurocognitive endophenotypes. Schizophr Bull 33:4968.
  • Hakko H, Wahlberg K-E, Tienari P, Rasanen S. 2011. Genetic vulnerability and premature death in schizophrenia spectrum disorders: A 28-year follow-up of adoptees in the Finnish Adoptive Family Study of Schizophrenia. Nord J Psychiatry 65:259265.
  • Harrison PJ, Weinberger DR. 2005. Schizophrenia genes, gene expression, and neuropathology: On the matter of their convergence. Mol Psychiatry 10:4068.
  • Husted JA, Lim S, Chow EW, Greenwood C, Bassett AS. 2009. Heritability of neurocognitive traits in familial schizophrenia. Am J Med Genet Part B Neuropsychiatr Genet 150B:845853.
  • Insel TR. 2010. Rethinking schizophrenia. Nature 468:187193.
  • Jablensky AV, Morgan V, Zubrick SR, Bower C, Yellachich LA. 2005. Pregnancy, delievery and neonatal complications in a population cohort of women with schizophrenia and major affective disorders. Am J Psychiatry 162:7991.
  • Kendler KS. 2001. Twin studies of psychiatric illness: An update. Arch Gen Psychiatry 58:10051014.
  • Kraepelin E. 1919/1971. Dementia praecox and paraphrenia. Huntington, NY: Robert Krieger.
  • Kremen WS, Seidman LJ, Pepple JR, Lyons MJ, Tsuang MT, Faraone SV. 1994. Neuropsychological risk indicators for schizophrenia: A review of family studies. Schizophr Bull 20:103119.
  • Kremen WS, Seidman LJ, Faraone SV, Toomey R, Tsuang MT. 2004. Heterogeity of schizophrenia: A study of individual neuropsychological profiles. Schizophr Res 71:307321.
  • Lencz T, Smith CW, Auther A, Correll CU, Cornblatt B. 2004. Nonspecific and attenuated negative symptoms in patients at clinical high risk for schizophrenia. Schizophr Res 68:3748.
  • McGlashan TH, Walsh B, Woods SW. 2010. The psychosis risk syndrome: Handbook for diagnosis and follow-up. New York: Oxford University Press.
  • McGorry PD, Purcell R, Goldstone S, Amminger GP. 2011. Age of onset and timing of treatment for mental and substance abuse disorders: Implications for preventive intervention strategies and models of care. Curr Opin Psychiatry 24:301306.
  • McGrath JJ. 2003. Gaining traction on the epidemiologic landscape of schizophrenia. Am J Epidemiol 158:301304.
  • McGrath J, Parker G. 2008. Seasonality and mental health: Mood disorders, suicide and schizophrenia. In: Freeman H, Stansfeld S, editors. The impact of the environment on psychiatric disorder. London: Routledge. pp. 268283.
  • Meehl PE. 1962. Schizotaxia, schizotypy, schizophrenia. Am Psychol 17:827838.
  • Meehl PE. 1989. Schizotaxia revisited. Arch Gen Psychiatry 46:935944.
  • Mesholam-Gately R, Giuliano AJ, Faraone SV, Goff KP, Seidman LJ. 2009. Neurocognition in first-episode schizophrenia: A meta-analytic review. Neuropsychology 23:315336.
  • Miller TJ, McGlashan TH, Rosen JL, Somjee L, Markovich P, et al. 2002. Prospective diagnosis of the initial prodrome for schizophrenia based on the Structured Interview for Prodromal Syndromes: Preliminary evidence of interrater reliability and predictive validity Am J Psychiatry 159:863865.
  • Miller TJ, McGlashan TH, Rosen JL, Cadenhead KS, Ventura J, et al. 2003. Prodromal assessment with the structured interview for prodromal syndromes and the scale of prodromal symptoms: Predictive validity, interrater reliability and training to reliability. Schizophr Bull 29:703715.
  • Mortensen PB, Pedersen MG, Pedersen CB. 2010. Psychiatric family history and schizophrenia risk in Denmark: Which mental disorders are relevant? Psychol Med 40:201210.
  • Niendam TA, Bearden CE, Johnson JK, McKinley M, Loewy R, et al. 2006. Neurocognitive performance and functional disability in the psychosis syndrome. Schizophr Res 84:100111.
  • Penn DL, Waldheter EJ, Perkins DO, Mueser KT, Lieberman JA. 2005. Psychosocial treatment for first-episode psychosis: A research update. Am J Psychiatry 162:22202232.
  • Preti A, Pisano A, Cascio MT, Monzani E, Meneghelli A, Cocchi A. 2012. Obstetric complications in early psychosis: Relation with family history of psychosis. Psychiatry Res 200:708714.
  • Rado S. 1953. Dynamics and clssification of disordered behavior. Am J Psychiatry 110:406416.
  • Rado S. 1960. Theory and therapy: The theory of schizotypal organization and its application to the treatment of decompensated schizotypal behavior. In: Scher SC, Davis HR, editors. The outpatient treatment of schizophrenia. New York: Grune & Stratton. pp. 87101.
  • Riecher-Rossler A, Gschewandtner U, Aston J, Borgwardt S, Drewe M, et al. 2007. The Basel early-detection-of-psychosis (FEPSY)-study: Design and preliminary results. Acta Pscyhiatr Scand 115:114125.
  • Rybakowski JK, Drozdz W, Borkowska A. 2007. Long-term administration of low-dose risperidone in schizotaxia subjects. Hum Psychopharmacol 22:407412.
  • Schlosser DA, Jacobson S, Chen Q, Sugar CA, Niendam TA, et al. 2012. Recovery from an at-risk state: Clinical and functional outcomes of putatively prodromal youth who do not develop psychosis. Schizophr Bull 38:12251233.
  • Scott WK, Hauser ER, Schmechel DE, Welsh-Bohmer KA, Small GW, et al. 2003. Ordered-subsets linkage analysis detects novel alzheimer disease loci on chromosome 2q4 and 15q22. Am J Hum Genet 73:10411051.
  • Seidman LJ, Wencel HE. 2003. Genetically mediated brain abnormalities in schizophrenia. Curr Psychiatry Rep 5:135144.
  • Siira V, Wahlberg K-E, Hakko H, Laksy K, Tienari P. 2007. Interaction of genetic vulnerability to schizophrenia and communication deviance of adoptive parents associated with MMPI schizophrenia vulnerability indicators of adoptees. Nord J Psychiatry 61:418426.
  • Simon AE, Umbricht D. 2010. High remission rates from an initial ultra-high risk state for psychosis. Schizophr Res 116:168172.
  • Simon AE, Roth B, Zmilacher S, Isler E, Umbricht D. 2007. Developing services for the early detection of psychosis: A critical consideration of the current state of the art. Eur Child Adolesc Psychiatry 16:96103.
  • Sitskoorn MM, Aleman A, Ebisch SJH, Appels MCM, Kahn RS. 2004. Cognitive deficits in relatives of patients with schizophrenia: A meta-analysis. Schizophr Res 71:285295.
  • Snitz BE, MacDonald III AW, Carter AS. 2006. Cognitive deficits in unaffected first-degree relatives of schizophrenia patients: A meta-analytic review of putative endophenotypes. Schizophr Bull 32:179194.
  • Stone WS, Faraone SV, Seidman LJ, Green AI, Wojcik JD, Tsuang MT. 2001. Concurrent validation of schizotaxia: A pilot study. Biol Psychiatry 50:434440.
  • Stone WS, Faraone SV, Seidman LJ, Olson EA, Tsuang MT. 2005. Searching for the liability to schizophrenia: Concepts and methods underlying genetic high-risk studies of adolescents. J Child Adolesc Psychopharmacol 15:403417.
  • Stone WS, Roe AH, Tsuang MT. 2007. Overlapping of the spectra: Physical comorbidity between schizophrenia and affective disorders. In: Marneros A, Akiskal AH, editors. The overlap of affective and schizophrenic spectra. Cambridge: Cambridge University Press. pp. 207223.
  • Stone WS, Hsi X, Giuliano AJ, Tan L, Zhu S, et al. 2012a. Are neurocognitive, clinical and social dysfunctions in schizotaxia reversible pharmacologically?: Results from the Changsha study. Asian J Psychiatry 5:7382.
  • Stone WS, Hsi X, Tan L, Zhu S, Li L, et al. 2012b. Neurocognitive and clinical dysfunction in adult Chinese, nonpsychotic relatives of patients with schizophrenia: Findings from the Changsha study and evidence for schizotaxia. Asian J Psychiatry 5:8392.
  • Sullivan HS 1994 The onset of schizophrenia Am J Psychiatry 151:135139
  • Suvisaari JM, Taxell-Lassas V, Pankakoski M, Haukka JK, Lonnqvist JK, Hakkinen LT, 2012. Obstetric complications as risk factors for schizophrenia spectrum psychoses in offspring of mothers with psychotic disorder. Schizophr Bull September 20 [Epub ahead of print].
  • Thaker GK. 2007. Endophenotypic studies in schizophrenia: Promises and challenges. Schizophr Bull 33:12.
  • Tienari P. 1991. Interaction between genetic vulnerability and family environment: The Finnish adoptive family study of schizophrenia. Acta Psychiatr Scand 84:460465.
  • Tienari P, Wynne LC, Moring J, Lahti I, Naarala M, et al. 1994. The Finnish adoptive family study of schizophrenia. Implications for family research. Br J Psychiatry 163:2026.
  • Tienari P, Wynne LC, Sorri A, Lahti I, Laksy K, et al. 2004. Gene–environment interaction in schizophrenia–spectrum disorder. Br J Psychiatry 184:216222.
  • Tsuang MT. 1994. Genetics, epidemiology and the search for the causes of schizophrenia. Am J Psychiatry 151:36.
  • Tsuang MT, Winokur G. 1975. The Iowa 500: Field work in a 35-year follow-up of depression, mania, and schizophrenia. Can Psychiatr Assoc J 20:359365.
  • Tsuang MT, Gilbertson MW, Faraone SV. 1991. Genetic transmission of negative and positive symptoms in the biological relatives of schizophrenics. In: Marneros A, Tsuang MT, Andreasen N, edition. Positive vs. negative schizophrenia. New York, NY: Springer-Verlag. pp. 265291.
  • Tsuang MT, Stone WS, Faraone SV. 1999a. Schizophrenia: A review of genetic studies. Harv Rev Psychiatry 7:185207.
  • Tsuang MT, Stone WS, Seidman LJ, Faraone SV, Zimmet S, et al. 1999b. Treatment of nonpsychotic relatives of patients with schizophrenia: Four case studies. Biol Psychiatry 41:14121418.
  • Tsuang MT, Stone WS, Faraone SV. 2000. Towards reformulating the diagnosis of schizophrenia. Am J Psychiatry 147:10411050.
  • Tsuang MT, Stone WS, Tarbox SI, Faraone SV. 2002. An integration of schizophrenia with schizotypy: Identification of schizotaxia and implications for research on treatment and prevention. Schizophr Res 54:169175.
  • Tsuang MT, Stone WS, Johnston JM. 2008. Gene–environment interactions in mental disorders: A current view. In: Freeman H, Stansfeld S, editors. The Impact of the environment on psychiatric disorder. London: Routledge. pp. 2751.
  • Tsuang MT, Stone WS, Auster TL. 2010. Prevention of schizophrenia. Expert Rev Neurotherapeut 10:11651174.
  • Tsuang MT, Stone WS, Genderson M, Lyons M. 2011. Early detection and intervention as approaches for preventing schizophrenia. In: Tsuang MT, Tohen M, Jones PB, editors. Texbook of psychiatric epidemiology. Oxford: Wiley-Blackwell. pp. 617631.
  • Turetsky BI, Calkins ME, Light GA, Olincy A, Radant AD, Swerdlow NR. 2007. Neurophysiological endophenotypes of schizophrenia: The viability of selected candidate measures. Schizophr Bull 33:6994.
  • Velthorst E, Nieman DH, Linszen D, Becker H, de Haan L, et al. 2010. Disability in people clinically at risk of psychosis. Br J Psychiatry 197:278284.
  • Wahlberg K-E, Wynne LC, Oja H, Keskitalo P, Pykalainen L, et al. 1997. Gene–environment interaction in vulnerability to schizophrenia: Findings from the Finnish adoptive family study in schizophrenia. Am J Psychiatry 154:355362.
  • Weiser M. 2011. Early intervention for schizophrenia: The risk-benefit ration of antipsychotic treatment in the prodromal phase. Am J Psychiatry 168:761763.
  • Weissman MM, Bothwell S. 1976. Assessment of social adjustment by patient self-report. Arch Gen Psychiatry 33:11111115.
  • Wicks S, Hjern A, Dalman C. 2010. Social risk or gentic liability for psychosis? A study of children born in Sweden and reared by adoptive parents. Am J Psychiatry 167:12401246.
  • Woods SW, Addington J, Cadenhead KS, Cannon TD, Cornblatt B, et al. 2009. Validity of the prodromal risk syndrome for first psychosis: Finding from the North American Prodromal Longitudinal Study. Schizophr Bull 35:894908.
  • Wynne LC, Tienari P, Nieminen P, Sorri A, Lahti I, et al. 2006. I. Genotype–environment interaction in the schizophrenia spectrum: Genetic liability and global family ratings in the Finnish Adoption study. Fam Processes 45:419434.
  • Yung AR, McGorry PD. 1996a. The initial prodrome in psychosis: Descriptive and qualitative aspects. Aust N Z J Psychiatry 30:587599.
  • Yung AR, McGorry PD. 1996b. The prodromal phase of first-episode psychosis: Past and current conceptualizations. Schizophr Bull 22:353370.
  • Yung AR, McGorry PD. 1996c. The prodromal phase of first-episode psychosis:past and current conceptualizations. Schizophr Bull 22:363370.
  • Yung AR, Phillips LJ, Yuen HP, Francey SM, McFarlane W, et al. 2003. Psychosis prediction: A 12-month follow-up of a high risk (“prodromal”) group. Schizophr Res 60:2132.
  • Yung AR, Yuen HP, McGorry PD, Phillips LJ, Kelly D, et al. 2005. Mapping the onset of psychosis: The comprehensive assessment of at-risk mental states. Aust N Z J Psychiatry 39:964971.
  • Yung AR, Buckby JA, Cosgrave EM, Killackey EJ, Baker K, et al. 2007. Association between psychotic experiences and depression in a clinical sample over 6 months. Schizophr Res 91:246253.
  • Yung AR, Nelson B, Stanford C, Simmons MB, Cosgrave EM, et al. 2008. Validation of “prodromal” criteria to detect individuals at ultra high risk of psychosis: 2 year follow-up. Schizophr Res 105:1017.
  • Zornberg GL, Buka SL, Tsuang MT. 2000. Hypoxic-ischemia-related fetal/neonatal complications and risk of schizophrenia and other nonaffective psychoses: A 19-year longitudinal study. Am J Psychiatry 157:196202.